Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2500
Single User License Price INR 175000
Corporate User License Price USD 3200
Corporate User License Price INR 224000
Request a Quote

Report Title

Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Quote Request for License Type
License Type Price  
Single User License USD 2500
Enterprise Wide License USD 3200
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025


Quote Request for License Type
License Type Price  
Single User License USD 2500
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025



Executive Summary

The Europe anti-nuclear antibody test market is expected to reach USD 491.05 million by 2025, from USD 268.98 million in 2017 growing at a CAGR of 7.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the growth of this market are increasing incidence of autoimmune diseases, rising medical insurance, and rise in government healthcare protection.

The key market players for Europe anti-nuclear antibody test market are listed below:

Bio-Rad Laboratories, Inc.

Alere, Inc.

Trinity Biotech

Thermo Fisher Scientific Inc.

Antibodies Inc.

EUROIMMUN AG

Immuno Concepts

The market is further segmented into:

Product

Test

Disease

End-user

The Europe anti-nuclear antibody test market is segmented on the basis of product into assay kits & reagents, systems, and software. In 2018, assay kits & reagents is expected to dominate the Europe anti-nuclear antibody test market with 59.2% market share and is expected to reach USD 294.67 million by 2025, with the highest CAGR of 8.1% in the forecast period 2018 to 2025.

The Europe anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the Europe anti-nuclear antibody test market with 59.9% market share and is expected to reach USD 284.10 million by 2025, with the CAGR of 7.4% in the forecast period 2018 to 2025. However, multiplex testing market segment is expected to grow at the highest CAGR of 9.2% in the forecast period, and is expected to reach USD 82.42 million in 2025 from USD 41.21 million in 2017.

The Europe anti-nuclear antibody test market is segmented on the basis of disease into systemic lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, scleroderma, polymyositis, and others. In 2018, systemic lupus erythematosus is expected to dominate the Europe anti-nuclear antibody test market with 51.3% market share and is expected to reach USD 256.05 million by 2025, with the highest CAGR of 8.2% in the forecast period 2018 to 2025.

The Europe anti-nuclear antibody test market is segmented on the basis of end-user into hospitals, clinics, physician office laboratories, and others. In 2018, hospitals is expected to dominate the Europe anti-nuclear antibody test market with 60.3% market share and is expected to reach USD 299.43 million by 2025, with the highest CAGR of 8.1% in the forecast period 2018 to 2025.

Based on geography, the Europe anti-nuclear antibody test market is segmented into geographical regions, such as,

Germany,

United Kingdom,

France,

Spain,

Italy,

Russia,

Turkey,

Belgium,

Nether lands,

Switzerland,

Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe anti-nuclear antibody test for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table Of Contents

1. Introduction 23

1.1. Objectives Of The Study 23

1.2. Market Definition 23

1.3. Overview Of Europe Anti-Nuclear Antibody Test Market 24

1.4. Currency And Pricing 24

1.5. Limitation 24

1.6. Markets Covered 25

2. Market Segmentation 27

2.1. Markets Covered 27

2.2. Geographic Scope 28

2.3. Years Considered For The Study 29

2.4. Currency And Pricing 29

2.5. Research Methodology 30

2.6. Primary Interviews With Key Opinion Leaders 33

2.7. Secondary Sources 34

2.8. Assumptions 34

3. Market Overview 35

3.1. Drivers 37

3.1.1. Increasing Incidence Of Autoimmune Diseases 37

3.1.2. Rising Medical Insurance 38

3.1.3. Rise In Government Healthcare Protection 39

3.2. Restraints 40

3.2.1. Strict Regulation For Product Approval 40

3.3. Opportunities 41

3.3.1. Increasing Growth In Healthcare Expenditure 41

3.3.2. Emerging Markets 43

3.3.3. Laboratory Automation Favors The Market 43

3.4. Challenges 44

3.4.1. Lack Of Skilled Professionals 44

4. Executive Summary 45

5. Premium Insights 48

6. Europe Anti-Nuclear Antibody Test Market, By Product 55

6.1. Overview 56

6.2. Assay Kits & Reagents 58

6.3. Systems 59

6.4. Software 60

7. Europe Anti-Nuclear Antibody Test Market, By Test 61

7.1. Overview 62

7.2. Indirect Immunofluorescence 64

7.3. Elisa 65

7.4. Multiplex Testing 66

8. Europe Anti-Nuclear Antibody Test Market, By Disease 67

8.1. Overview 68

8.2. Rheumatoid Arthritis 70

8.3. Systemic Lupus Erythematosus 71

8.4. Sjogren'S Syndrome 72

8.5. Scleroderma 73

8.6. Polymyositis 74

8.7. Others 75

9. Europe Anti-Nuclear Antibody Test Market, By End User 76

9.1. Overview 77

9.2. Hospitals 79

9.3. Clinics 80

9.4. Physician Office Laboratories 81

9.5. Others 82

10. Europe Anti-Nuclear Antibody Test Market, By Geography 83

10.1. Overview 84

10.2. Europe 110

10.2.1. Germany 120

10.2.2. France 123

10.2.3. U.K. 126

10.2.4. Italy 129

10.2.5. Spain 132

10.2.6. Switzerland 135

10.2.7. Netherlands 138

10.2.8. Belgium 141

10.2.9. Russia 144

10.2.10. Turkey 147

10.2.11. Rest Of Europe 150

11. Europe Anti-Nuclear Antibody Test Market,

Company Landscape 220

11.1. Company Share Analysis: Europe 220

11.2. Company Share Analysis: North America 221

11.3. Company Share Analysis: Europe 222

11.4. Company Share Analysis: Asia Pacific 223

12. Company Profiles 224

12.1. Thermo Fisher Scientific Inc. 224

12.1.1. Company Overview 224

12.1.2. Thermo Fisher Scientific Inc.:Revenue Analysis 224

12.1.3. Product Portfolio 225

12.1.4. Recent Developments 225

12.2. Merck Kgaa 226

12.2.1. Company Overview 226

12.2.2. Merck Kgaa: Revenue Analysis 226

12.2.3. Product Portfolio 227

12.2.4. Recent Developments 227

12.3. Alere Inc. 228

12.3.1. Company Overview 228

12.3.2. Alere Inc.: Revenue Analysis 228

12.3.3. Product Portfolio 229

12.3.4. Recent Developments 229

12.4. Trinity Biotech 230

12.4.1. Company Overview 230

12.4.2. Trinity Biotech: Company Overview 230

12.4.3. Product Portfolio 231

12.4.4. Recent Developments 231

12.5. Antibodies Inc. 232

12.5.1. Company Overview 232

12.5.2. Antibodies Inc.: Revenue Analysis 232

12.5.3. Product Portfolio 232

12.5.4. Recent Developments 232

12.6. Bio-Rad Laboratories, Inc. 233

12.6.1. Company Overview 233

12.6.2. Bio-Rad Laboratories, Inc.: Company Snapshot 233

12.6.3. Product Portfolio 234

12.6.4. Recent Developments 234

12.7. Euroimmun Ag (A Subsidiary Of Perkinelmer Inc.) 235

12.7.1. Company Overview 235

12.7.2. Perkinelmer Inc.: Revenue Analysis 235

12.7.3. Product Portfolio 236

12.7.4. Recent Developments 236

12.8. Immuno Concepts 237

12.8.1. Company Overview 237

12.8.2. Immuno Concepts: Company Snapshot 237

12.8.3. Product Portfolio 238

12.8.4. Recent Developments 238

12.9. Inova Diagnostics 239

12.9.1. Company Overview 239

12.9.2. Inova Diagnostics:Company Snapshot 239

12.9.3. Product Portfolio 239

12.9.4. Recent Developments 240

12.10. Zeus Scientific, Inc. 240

12.10.1. Company Overview 240

12.10.2. Zeus Scientific, Inc.: Company Snapshot 240

12.10.3. Product Portfolio 241

12.10.4. Recent Developments 242

12.11. Mbl International 243

12.11.1. Company Overview 243

12.11.2. Mbl International: Company Snapshot 243

12.11.3. Product Portfolio 244

12.11.4. Recent Developments 244

12.12. Medsource Ozone Biomedicals Pvt. Ltd 245

12.12.1. Company Overview 245

12.12.2. Medsource Ozone Biomedicals Pvt. Ltd: Company Snapshot 245

12.12.3. Product Portfolio 245

12.12.4. Recent Developments 245

12.13. Aesku Group Gmbh & Co. Kg 246

12.13.1. Company Overview 246

12.13.2. Aesku Group Gmbh & Co. Kg: Company Snapshot 246

12.13.3. Product Portfolio 247

12.13.4. Recent Developments 247

13. Related Reports 248

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Figures List

Figure 1 Europe Anti-Nuclear Antibody Test Market: Segmentation 27

Figure 2 Europe Anti-Nuclear Antibody Test Market: Data Triangulation 30

Figure 3 Europe Anti-Nuclear Antibody Test Market : Research Snapshot 31

Figure 4 Europe Anti-Nuclear Antibody Test Market : Bottom Up Approach 32

Figure 5 Europe Anti-Nuclear Antibody Test Market: Top Down Approach 32

Figure 6 Europe Anti-Nuclear Antibody Test Market :

Interview Demographics 33

Figure 7 Europe Anti-Nuclear Antibody Test Market : Segmentation 46

Figure 8 Europe Anti-Nuclear Antibody Test Market: By Product Type, 2017 56

Figure 9 Europe Anti-Nuclear Antibody Test Market: By Test, 2017 62

Figure 10 Europe Anti-Nuclear Antibody Test Market: By Disease, 2017 68

Figure 11 Europe Anti-Nuclear Antibody Test Market: By End User, 2017 77

Figure 12 Europe Anti-Nuclear Antibody Test Market Snapshot (2017) 85

Figure 13 Europe Anti-Nuclear Antibody Test Market: By Geography (2017) 86

Figure 14 Europe Anti-Nuclear Antibody Test Market: By Geography (2018) 87

Figure 15 Europe Anti-Nuclear Antibody Test Market: By Country (2017 & 2025) 88

Figure 16 Europe Anti-Nuclear Antibody Test Market:

By Product Type (2018 & 2025) 89

Figure 17 Europe Anti-Nuclear Antibody Test Market: Snapshot (2017) 111

Figure 18 Europe Anti-Nuclear Antibody Test Market: By Country (2017) 112

Figure 19 Europe Anti-Nuclear Antibody Test Market :

By Country (2018 & 2025) 113

Figure 20 Europe Anti-Nuclear Antibody Test Market, By Country (2017 & 2025) 114

Figure 21 Europe Anti-Nuclear Antibody Test Market, By Product (2018 & 2025) 115

Figure 22 Europe Anti-Nuclear Antibody Test Market: Company Share 2017 (%) 222

TABLE 1 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 57

TABLE 2 EUROPE ASSAY KITS & REAGENTS MARKET, BY REGION,

2016-2025 (USD MILLION) 58

TABLE 3 EUROPE SYSTEMS MARKET, BY REGION, 2016-2025 (USD MILLION) 59

TABLE 4 EUROPE SOFTWARES MARKET, BY REGION, 2016-2025 (USD MILLION) 60

TABLE 5 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY TEST,

2016-2025 (USD MILLION) 63

TABLE 6 EUROPE INDIRECT IMMUNOFLUORESCENCE MARKET, BY REGION,

2016-2025 (USD MILLION) 64

TABLE 7 EUROPE ELISA MARKET, BY REGION, 2016-2025 (USD MILLION) 65

TABLE 8 EUROPE MULTIPLEX TESTING MARKET, BY REGION,

2016-2025 (USD MILLION) 66

TABLE 9 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 69

TABLE 10 EUROPE RHEUMATOID ARTHRITIS MARKET, BY REGION,

2016-2025 (USD MILLION) 70

TABLE 11 EUROPE SYSTEMIC LUPUS ERYTHEMATOSUS MARKET, BY REGION,

2016-2025 (USD MILLION) 71

TABLE 12 EUROPE SJOGREN'S SYNDROME MARKET, BY REGION,

2016-2025 (USD MILLION) 72

TABLE 13 EUROPE SCLERODERMA MARKET, BY REGION,

2016-2025 (USD MILLION) 73

TABLE 14 EUROPE POLYMYOSITIS MARKET, BY REGION, 2016-2025 (USD MILLION) 74

TABLE 15 EUROPE OTHERS MARKET, BY REGION, 2016-2025 (USD MILLION) 75

TABLE 16 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 78

TABLE 17 EUROPE HOSPITALS MARKET, BY REGION, 2016-2025 (USD MILLION) 79

TABLE 18 EUROPE CLINICS MARKET, BY REGION, 2016-2025 (USD MILLION) 80

TABLE 19 EUROPE PHYSICIAN OFFICE LABORATORIES MARKET, BY REGION,

2016-2025 (USD MILLION) 81

TABLE 20 EUROPE OTHERS MARKET, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 21 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY REGION,

2016-2025 (USD MILLION) 90

TABLE 22 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET, BY COUNTRY,

2016-2025 (USD MILLION) 116

TABLE 23 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 117

TABLE 24 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 117

TABLE 25 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 118

TABLE 26 EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 119

TABLE 27 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 120

TABLE 28 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 120

TABLE 29 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 121

TABLE 30 GERMANY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 122

TABLE 31 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 123

TABLE 32 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 123

TABLE 33 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 124

TABLE 34 FRANCE ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 125

TABLE 35 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 126

TABLE 36 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 126

TABLE 37 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 127

TABLE 38 U.K. ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 128

TABLE 39 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 129

TABLE 40 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 129

TABLE 41 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 130

TABLE 42 ITALY ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 131

TABLE 43 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 132

TABLE 44 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 132

TABLE 45 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 133

TABLE 46 SPAIN ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 134

TABLE 47 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY PRODUCT,

2016-2025 (USD MILLION) 135

TABLE 48 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY TEST,

2016-2025 (USD MILLION) 135

TABLE 49 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY DISEASE,

2016-2025 (USD MILLION) 136

TABLE 50 SWITZERLAND ANTI-NUCLEAR ANTIBODY TEST MARKET , BY END USER,

2016-2025 (USD MILLION) 137

TABLE 51 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016-2025 (USD MILLION) 138

TABLE 52 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016-2025 (USD MILLION) 138

TABLE 53 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016-2025 (USD MILLION) 139

TABLE 54 NETHERLANDS ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016-2025 (USD MILLION) 140

TABLE 55 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016-2025 (USD MILLION) 141

TABLE 56 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016-2025 (USD MILLION) 141

TABLE 57 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016-2025 (USD MILLION) 142

TABLE 58 BELGIUM ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016-2025 (USD MILLION) 143

TABLE 59 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016-2025 (USD MILLION) 144

TABLE 60 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016-2025 (USD MILLION) 144

TABLE 61 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016-2025 (USD MILLION) 145

TABLE 62 RUSSIA ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016-2025 (USD MILLION) 146

TABLE 63 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016-2025 (USD MILLION) 147

TABLE 64 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY TEST, 2016-2025 (USD MILLION) 147

TABLE 65 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY DISEASE, 2016-2025 (USD MILLION) 148

TABLE 66 TURKEY ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY END USER, 2016-2025 (USD MILLION) 149

TABLE 67 REST OF EUROPE ANTI-NUCLEAR ANTIBODY TEST MARKET ,

BY PRODUCT, 2016-2025 (USD MILLION) 150

Bio-Rad Laboratories, Inc.

Alere, Inc.

Trinity Biotech

Thermo Fisher Scientific Inc.

Antibodies Inc.

EUROIMMUN AG

Immuno Concepts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person